Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from NICE

Breast cancer charity slams NHS drug approval process

IN FULL

The Independent UK

Thousands of cancer patients denied key drug due to ‘unfair’ NHS rulings, says charity

Charity Breast Cancer Now says the process for NHS drug approval is ‘unfair’

The Independent UK

Breast cancer patients ‘denied life-extending drugs because of unfair system’

Breast Cancer Now has demanded ‘immediate action’ from Health Secretary Wes Streeting.

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

London hospital failed to give woman 'prompt and necessary' sepsis care - coroner

An inquest concluded that Norma Campbell died of natural causes, contributed to by neglect

Evening Standard

PP Arnold on her star-studded life in music: ‘Peter Gabriel and I used to hang upside down in gravity boots’

After singing with everyone from Tina Turner to the Small Faces, she takes your questions on her Glastonbury plans, life as an Ikette and getting a leg up from Mick Jagger

The Guardian - UK

Ranked! The 50 best managers in the world right now

The best managers in the world, from the tinkermen to the tacticos and everyone in between

FourFourTwo

The real reason two ‘miracle’ Alzheimer’s drugs were rejected for NHS use

ANALYSIS: Paul Atkinson and Sally Sheard say the decision reflects a cautious and evidence-based approach that protects patients and public funds

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

Why Nice was right to say no – for now – to new Alzheimer’s drugs

The UK’s National Institute for Health and Care Excellence (Nice) has declined to recommend two new Alzheimer’s drugs for routine NHS use in England. While disappointing for some families affected by dementia, this decision reflects a cautious and evidence-based approach that protects patients and public funds.

The Conversation

Why two Alzheimer’s drugs were rejected for use on the NHS

IN FULL

The Independent UK

Alzheimer’s drugs rejected for NHS because benefits ‘too small’ to justify cost

Donanemab and lecanemab are targeted antibody drugs that slow down the early stages of Alzheimer’s.

Evening Standard

Why your doctor may not have given you the best advice for your lower back pain

Treating lower back pain is enormously expensive. In the UK it’s estimated to cost the NHS around £3.2 billion a year. So, ensuring patients get the right treatment is critical.

The Conversation

Why the NHS may never use breakthrough Alzheimer’s drugs

IN FULL

The Independent UK

Thousands of NHS patients denied breakthrough Alzheimer’s drugs

Drugs that slow progression of Alzheimer’s don’t provide enough benefit to justify substantial cost for NHS, regulator has said

The Independent UK

Parents of 10-year-old twins with same debilitating illness describe ‘nightmare’ NHS battle

‘It’s so close – and yet we’re stuck,’ says mother of twins with rare muscular disorder

The Independent UK

Get all your
news in one place.

100's of premium titles.
One news app.

FourFourTwo

Manchester United 'banned' from signing no.1 target this summer: report

It's a blunder for Manchester United owners INEOS on this occasion

The Independent UK

Thousands could be saved by making this small change to heart failure treatment

Giving medication up to a year earlier could save thousands of lives, Nice say

Evening Standard

Around 3,000 lives could be saved ‘by changes to heart failure treatment’

Some 614,000 adults in England are affected by heart failure.

Sports Illustrated

Barcelona Pocket Surprise Windfall As €39 Million Transfer Confirmed

Why West Ham’s signing of Jean-Clair Todibo has earned Barcelona some extra money.

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Weight-loss drugs among breakthrough trials offering ‘hope’ for dementia prevention

One clinical trial is assessing whether semaglutide, used in weight loss drugs, could slow the progression of dementia

The Independent UK

Denying joint operations to obese patients is counterproductive

THE INDEPENDENT VIEW: Editorial: Rationing healthcare inevitably means difficult choices, but hip and knee replacements can help people lose weight

The National (Scotland)

Who is Francesco Farioli? Rangers manager contender profiled after talks

The National (Scotland)

Activists stage sit-in at Glasgow City Chambers over Israeli-linked CCTV software

ACTIVISTS have staged a sit-in demonstration at Glasgow City council chambers, calling for the council to remove Israeli military-founded CCTV…

FourFourTwo

A guide to multi-club ownership: How does it work?

Multi-club ownership is exactly what it sounds like: football clubs that have affiliate clubs, all under the umbrella of one person or company

Creative Bloq

Watch out Amazon, there's a new smile logo in town

Charity NABS gets a vibrant new look thanks to Nice and Serious.

The Conversation

Endometriosis: daily pill to manage symptoms will soon be available on the NHS – here’s how linzagolix works

A daily pill to treat endometriosis has just been recommended by the National Institute for Health and Care Excellence (Nice). Once available on the NHS, linzagolix will provide a new treatment option for those who have been unable to manage the condition using other standard treatments.

1 … 5 6 7 8

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

UEFA Champions League

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.